Royal Bank of Canada Lowers Pacira BioSciences (NASDAQ:PCRX) Price Target to $37.00
Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target reduced by Royal Bank of Canada from $42.00 to $37.00 in a research note published on Wednesday, Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also recently issued reports on the company. Truist Financial cut […]
More Stories
Simmons Bank Acquires New Holdings in Invesco Dividend Achievers ETF (NASDAQ:PFM)
Simmons Bank purchased a new stake in shares of Invesco Dividend Achievers ETF (NASDAQ:PFM – Free Report) in the 3rd...
Harbour Investments Inc. Sells 838 Shares of Tema American Reshoring ETF (NYSEARCA:RSHO)
Harbour Investments Inc. cut its holdings in Tema American Reshoring ETF (NYSEARCA:RSHO – Free Report) by 2.3% during the 3rd...
Entropy Technologies LP Cuts Stock Position in Skyworks Solutions, Inc. (NASDAQ:SWKS)
Entropy Technologies LP lessened its holdings in Skyworks Solutions, Inc. (NASDAQ:SWKS – Free Report) by 82.2% in the 3rd quarter,...
Harbour Investments Inc. Acquires 150 Shares of Quanta Services, Inc. (NYSE:PWR)
Harbour Investments Inc. raised its holdings in shares of Quanta Services, Inc. (NYSE:PWR – Free Report) by 3.7% in the...
Wintrust Financial Co. (NASDAQ:WTFCM) Short Interest Update
Wintrust Financial Co. (NASDAQ:WTFCM – Get Free Report) was the recipient of a large increase in short interest in October....
Short Interest in WISeKey International Holding AG (NASDAQ:WKEY) Drops By 52.4%
WISeKey International Holding AG (NASDAQ:WKEY – Get Free Report) was the target of a significant drop in short interest in...